Paper
26 May 2023 Application of machine learning in anti-pancreatic cancer drugs
Li Yue
Author Affiliations +
Proceedings Volume 12700, International Conference on Electronic Information Engineering and Data Processing (EIEDP 2023); 127003C (2023) https://doi.org/10.1117/12.2682341
Event: International Conference on Electronic Information Engineering and Data Processing (EIEDP 2023), 2023, Nanchang, China
Abstract
Estrogen Receptor is closely linked to the growth of breast cancer, and breast tumor cells significantly depend on Estrogen Receptor. Therefore, it is of great practical significance to find compounds that can antagonize ERα activity as candidate drugs for the treatment of breast cancer. In drug research, the method of establishing compound activity prediction model is usually used to screen potential active compounds. In this paper, according to the provided ERα antagonist information, based on the screened biologically active compounds, the ADMET properties of the compounds were predicted by three different classification models. Predictive modeling studies were carried out; finally, the value range of each element in ADMET properties was imprecisely optimized to better guide the selection of anti-breast cancer drug candidates.
© (2023) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Li Yue "Application of machine learning in anti-pancreatic cancer drugs", Proc. SPIE 12700, International Conference on Electronic Information Engineering and Data Processing (EIEDP 2023), 127003C (26 May 2023); https://doi.org/10.1117/12.2682341
Advertisement
Advertisement
RIGHTS & PERMISSIONS
Get copyright permission  Get copyright permission on Copyright Marketplace
KEYWORDS
Data modeling

Machine learning

Random forests

Education and training

Back to Top